StockDriftsStockDriftsAtaiBeckley Inc. has 4 SEC filings in the last 90 days, latest: Apeiron Investment Group ceases beneficial ownership after merger (13D/A, September 14, 2026). Each filing below is summarised from the document itself and links straight to the original on SEC EDGAR.
The company completed its merger with Eli Lilly, with each share converted to $6.75 cash plus one CVR, and its shares were delisted from Nasdaq.
Stockholders approved the merger agreement with Eli Lilly and Company, with 237,762,253 votes for the proposal.
The waiting period under the Hart-Scott-Rodino Act for the merger with Eli Lilly expired, and the UK CMA had no further questions.
Apeiron Investment Group Ltd. and its affiliates ceased beneficial ownership of AtaiBeckley Inc. shares following a merger with Eli Lilly and Company.